AOD-9604 dosage

AOD-9604 oral dosage

Reported-use amounts for AOD-9604 are ~1 mg per administration, daily, for approximately 24 wk.[8]

AOD-9604 is a modified growth-hormone fragment associated with fat-metabolism signaling. It is a different molecule from the native HGH fragment 176–191 and does not provide full growth-hormone replacement.[7][1][2][8]

AOD-9604 injectable dosage

Reported-use amounts for AOD-9604 are 250–500 mcg per administration, 1–2x daily, for 8–12 wk. One reported once-daily subcutaneous progression uses 250 mcg during weeks 1–4, followed by 500 mcg during weeks 5–12. This describes an 8–12-week course without the twice-daily frequency of some other reported patterns.[8][9]

AOD-9604 is a modified growth-hormone fragment associated with fat-metabolism signaling. It is a different molecule from the native HGH fragment 176–191 and does not provide full growth-hormone replacement.[3][4][1][2][8]

Frequency and timing

Morning is the listed timing for oral use. Injections are commonly timed in the morning or before a workout.[5][6][7][8]

Cycle length and breaks

Oral: ~24 wk. Injectable: 8–12 wk. A standard break interval between courses is not established.[8]

Approval and product quality

AOD-9604 is not an FDA-approved drug.[4][3]

Side effects and long-term safety

Human long-term safety, dose-response and route-specific risks remain unresolved. Clinical usefulness is limited; product purity and FDA compounding concerns require separate attention.[3][4]

Route-specific dosing limits

The main cautions are FDA compounding safety concerns, unapproved-product quality, sports prohibition, and missing safety support for special populations. Reported-use oral and injectable schedules and additional protocol patterns are not established human treatment regimens or approved product instructions.[3][4][9][8]